GCC Coronary and Peripheral Stents Market Outlook (2022-2033)

The GCC coronary and peripheral stents market size is expected to reach US$ 171.6 million by 2033 from US$ 122.0 million in 2024. The market is estimated to record a CAGR of 3.9% from 2025 to 2033.

Executive Summary and GCC Coronary and Peripheral Stents Market Analysis:

The GCC coronary and peripheral stents market is steadily expanding, supported by rising cardiovascular disease prevalence, lifestyle-related risk factors, and increasing investments in advanced healthcare infrastructure. As a region, the GCC benefits from high per capita healthcare spending, strong government initiatives, and rapid adoption of minimally invasive procedures. Saudi Arabia dominates the market, leveraging its large population base, extensive hospital network, and ambitious healthcare transformation programs under Vision 2030. Demand for drug‑eluting and peripheral nitinol stents is rising as interventional cardiology becomes more accessible across major cities. However, restraints include reliance on imported devices, regulatory delays in product approvals, and uneven access in smaller Gulf states. Despite these challenges, the GCC remains a strategically important market, with Saudi Arabia setting the pace for innovation, clinical adoption, and regional procurement strategies that influence broader device penetration.

GCC Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.   

GCC Coronary and Peripheral Stents Market Outlook

The GCC market is characterized by strong demand for coronary drug‑eluting stents and peripheral stents, with hospitals and specialty clinics driving adoption. The region’s healthcare systems are increasingly aligned with global interventional cardiology practices, supported by structured government funding and private sector participation. A key driver is government-led healthcare transformation, particularly in Saudi Arabia, where Vision 2030 emphasizes modernization of hospitals, expansion of catheterization labs, and integration of advanced medical technologies. This policy framework accelerates stent adoption by ensuring infrastructure readiness, physician training, and streamlined procurement pathways. As healthcare facilities expand and modernize, procedural volumes rise, reinforcing demand for technologically advanced stents. This driver not only boosts utilization but also encourages multinational manufacturers to strengthen their presence in the GCC, ensuring access to a wide range of coronary and peripheral solutions.

GCC Coronary and Peripheral Stents Market Country Insights

Based on country, the GCC coronary and peripheral stents market is further segmented into Saudi Arabia, the United Arab Emirates (UAE), Qatar, Kuwait, Bahrain, and Oman. Saudi Arabia held the largest share in 2024.

Saudi Arabia dominates the GCC coronary and peripheral stents market, driven by its large patient population, advanced hospital infrastructure, and strong government commitment to healthcare modernization. The country’s Vision 2030 reforms prioritize cardiovascular care, leading to significant investments in catheterization labs, physician training, and procurement of advanced stent technologies. Multinational leaders such as Abbott, Boston Scientific, and Medtronic maintain strong market presence, complemented by regional distributors that ensure device availability across major cities. Drug‑eluting stents are widely adopted as the standard of care, while peripheral stent usage is expanding in response to rising cases of peripheral artery disease. Saudi Arabia’s centralized procurement systems and structured reimbursement policies facilitate timely access to innovative devices, reinforcing its leadership position. With continuous infrastructure development and clinical expertise, Saudi Arabia sets the benchmark for coronary and peripheral stent utilization across the GCC, shaping regional adoption trends and market growth.

GCC Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

GCC Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

GCC Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations